Grants8

Search for grants with us!

Keywords

You can filter by below criteria

Grants

Grants you might be eligible for

Grant Information Key Details Eligibility & Funding

Accelerating the Pace of Substance Use Research Using Existing Data

RFA-DA-26-056

Programme: NIH Grants

General Overview

  • Grant name: Accelerating the Pace of Substance Use Research Using Existing Data
  • Funding organization: National Institutes of Health (NIH)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to 275000.00 USD

Deadline

Dec. 3, 2025, 10 p.m.

Details

Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)

PAR-25-037

Programme: NIH Grants

General Overview

  • Grant name: Cellular and Molecular Biology of Complex Brain Disorders
  • Funding organization: National Institutes of Health (NIH), National Institute of Mental Health (NIMH)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to 200000.00 USD

Deadline

June 16, 2026, 10 p.m.

Details

Innovation Grants to Nurture Initial Translational Efforts (IGNITE)

PAR-25-060

Programme: NIH IGNITE Program

General Overview

  • Grant name: Innovation Grants to Nurture Initial Translational Efforts (IGNITE)
  • Funding organization: National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to 499000.00 USD

Deadline

Oct. 20, 2027, 10 p.m.

Details

Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders

PAR-24-267

Programme: NIH Grants

General Overview

  • Grant name: Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders
  • Funding organization: National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to 250000.00 USD

Deadline

July 28, 2025, 10 p.m.

Details

Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional)

RFA-MH-25-206

Programme: NIH Grants

General Overview

  • Grant name: Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional)
  • Funding organization: National Institutes of Health (NIH), specifically the National Institute of Mental Health (NIMH)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to 200000.00 USD

Deadline

Oct. 20, 2025, 10 p.m.

Details

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders

PAR-25-184

Programme: National Institutes of Health (NIH)

General Overview

  • Grant name: Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders
  • Funding organization: National Institutes of Health (NIH)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to None USD

Deadline

Feb. 17, 2027, 10 p.m.

Details

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

PAR-25-226

Programme: NIH Grants

GRANT OVERVIEW

  • Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD)
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local, state, and federal governments, and foreign organizations.
  • Specific qualifications include having an eRA Commons account for Program Directors/Principal Investigators.

Funding

Up to None USD

Deadline

Nov. 19, 2026, 10 p.m.

Details

Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)

PAR-25-055

Programme: NIH Grants

General Overview

  • Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
  • National Institutes of Health (NIH)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to None USD

Deadline

June 22, 2026, 10 p.m.

Details

Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes

PAR-25-206

Programme: NIH Research Project Grant

General Overview

  • Grant name: Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes
  • Funding organization: National Institutes of Health (NIH), National Institute of Mental Health (NIMH)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to 750000.00 USD

Deadline

Oct. 5, 2027, 10 p.m.

Details

Novel Mechanism Research on Neuropsychiatric Symptoms in Alzheimer's Dementia

PAR-25-064

Programme: NIH Grants

General Overview

  • Grant name: Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
  • Funding organization: National Institutes of Health (NIH)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to 200000.00 USD

Deadline

June 16, 2026, 10 p.m.

Details

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

PAR-25-158

Programme: NIH Grants

General Overview

  • Grant name: Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
  • Funding organization: National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to 500000.00 USD

Deadline

Nov. 18, 2026, 10 p.m.

Details

NIAID Clinical Trial Implementation Cooperative Agreement (U01)

PAR-24-100

Programme: NIAID Clinical Trial Implementation

General Overview

  • Funding Opportunity Title: NIAID Clinical Trial Implementation Cooperative Agreement (U01)
  • Funding Organization: National Institutes of Health (NIH)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to None USD

Deadline

Jan. 13, 2027, 10 p.m.

Details

Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)

PAR-23-060

Programme: NIH Grants

General Overview

  • Grant name: Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
  • Funding organization: National Institutes of Health (NIH)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to 450000.00 USD

Deadline

Jan. 9, 2026, 10 p.m.

Details

Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases

PAR-23-032

Programme: Small Business Innovation Research (SBIR)

General Overview

  • Grant name: Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases
  • Funding organization: National Institutes of Health (NIH)

Organizational Aspects

  • Eligible organization types: Only United States small business concerns (SBCs).
  • Specific qualifications: Must be organized for profit and primarily operate within the U.S.

Funding

Up to 2000000.00 USD

Deadline

Sept. 5, 2025, 10 p.m.

Details

Centers for AIDS Research (P30 Clinical Trial Not Allowed)

PAR-23-116

Programme: Centers for AIDS Research

General Overview

  • Funding Opportunity Title: Centers for AIDS Research (P30 Clinical Trial Not Allowed)
  • Funding Organization: National Institutes of Health (NIH)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to 3250000.00 USD

Deadline

Aug. 5, 2025, 5 p.m.

Details

Avenir Award Program for Research on Substance Use Disorders and HIV

PAR-23-125

Programme: NIH Director’s New Innovator Awards

General Overview

  • Grant name: Avenir Award Program for Research on Substance Use Disorders and HIV
  • Funding organization: National Institutes of Health (NIH)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to 1500000.00 USD

Deadline

Aug. 16, 2025, 10 p.m.

Details

Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)

PAS-22-196

Programme: Small Business Innovation Research (SBIR)

General Overview

  • Funding organization: National Institutes of Health (NIH)
  • Total funding amount: Estimated $20 million for fiscal year 2023

Organizational Aspects

  • Eligible organization types: U.S. small business concerns (SBCs)
  • Qualifications: Must be organized for profit, with a place of business in the U.S.

Funding

Up to 2500000.00 USD

Deadline

Sept. 5, 2025, 5 p.m.

Details

Commercial Fishing Occupational Safety Research Cooperative Agreement (U01)

RFA-OH-22-005

Programme: CDC and NIOSH Funding

General Overview

  • Grant name: Commercial Fishing Occupational Safety Research Cooperative Agreement (U01)
  • Funding organization: Centers for Disease Control and Prevention (CDC) and National Institute for Occupational Safety and Health (NIOSH)

Organizational Aspects

  • Eligible organization types: Academia, non-profit organizations, businesses involved in fishing and maritime matters
  • Specific qualifications: Expertise in commercial fishing safety

Funding

Up to 975000.00 USD

Deadline

Jan. 26, 2027, 10 p.m.

Details

NIDA Research Center of Excellence Grant Program

PAR-23-076

Programme: NIDA Research Center of Excellence Grant Program

General Overview

  • Grant name: NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
  • Funding organization: National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to 10000000.00 USD

Deadline

Sept. 25, 2025, 10 p.m.

Details

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain

RFA-DC-24-001

Programme: BRAIN Initiative

General Overview

  • BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain
  • National Institutes of Health (NIH)

Organizational Aspects

  • Higher Education Institutions
  • Public/State Controlled Institutions of Higher Education

Funding

Up to 700000.00 USD

Deadline

Sept. 19, 2025, 10 p.m.

Details

440 results. Page 6 of 22.